Impact assessment of the inclusion of ABCB1 and CYP4F2 genes polymorphisms in phar...
Pharmacogenetic of cardiovascular system drugs focusing on implementation
Pharmacogenetic analysis using warfarin drug and in the Brazilian general population
Clinical characteristics and structural changes in MRI: importance for the outcome...
Polygenic risk score related to energy intake regulation and association with body...
Pharmacogenetics and pharmacometabolomics analyses for antihypertensive drugs
Involvement of HCP5 polymorphism in age at onset of Graves' disease